HSV529 Vaccine in HSV-2 Seropositive Adults

Clinical trial NCT02571166 · COMPLETED

Trial details

NCT number: NCT02571166
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Herpes Simplex Virus 2

Start date: 2015-11-01
Primary completion: 2018-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.